Sunday, June 21, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 469 of 1,261
  1. US 10434069

    Protease assisted native-protein delivery approach (PANDA)

    The Regents of the University of California · Granted Oct 8, 2019 · Expires Oct 3, 2039

    granted
  2. US 10435695

    Fusion protein comprising Gaussia luciferase, translation interrupter sequence, and interferon amino acid sequences

    The Government of the United States of America, as represented by the Secretary of Homeland Security · Granted Oct 8, 2019 · Expires Oct 3, 2039

    granted
  3. US 10434174

    Combination therapies using platinum agents and agents that target tumor-associated stroma or tumor cells

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 8, 2019 · Expires Oct 3, 2039

    granted
  4. US 10434114

    Methods of treating a bacterial infection using a fixed-dose pharmaceutical composition comprising three antibiotics

    RedHill Biopharma Ltd. · Granted Oct 8, 2019 · Expires Oct 3, 2039

    granted
  5. US 10434078

    GABA agonists in the treatment of disorders associated with metabolic syndrome and GABA combinations in treatment or prophylaxis of type I diabetes

    The Regents of the University of California · Granted Oct 8, 2019 · Expires Oct 3, 2039

    granted
  6. US 10434116

    Methods of treating coronavirus infection

    United States Government as represented by the Secretary, Department of Health and Human Services · Granted Oct 8, 2019 · Expires Oct 3, 2039

    granted
  7. US 10435677

    Genetically modified human cell with a corrected mutant sickle cell mutation

    Sangamo Therapeutics, Inc. · Granted Oct 8, 2019 · Expires Oct 3, 2039

    granted
  8. US 10435399

    HDAC6 inhibitory heterocyclic compound

    Takeda Pharmaceutical Company Limited · Granted Oct 8, 2019 · Expires Oct 3, 2039

    granted
  9. US 10435373

    Drug for inhibiting aggregation of proteins involved in diseases linked to protein aggregation and/or neurodegenerative diseases

    Ludwig-Maximilians-Universitat Munchen · Granted Oct 8, 2019 · Expires Oct 3, 2039

    granted
  10. US 2019298716

    Aripiprazole Dosing Strategy

    ALKERMES PHARMA IRELAND LTD [IE] · Granted Oct 3, 2019 · Expires Sep 28, 2039

    granted
  11. CA 3095083

    ASSOCIATION COMPRENANT UN INHIBITEUR DE HDAC ET UN AGONISTE DE CD137 POUR LA THERAPIE DU CANCER

    4SC AG [DE] · Granted Oct 3, 2019 · Expires Sep 28, 2039

    granted
  12. US 10426830

    Altering the immundominance hierarchy using a DNA vaccine expressing conserved regions

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 1, 2019 · Expires Sep 26, 2039

    granted
  13. US 10428057

    Bicyclo[1.1.1]pentane inhibitors of dual leucine zipper (DLK) kinase for the treatment of disease

    The Board of Regents of the University of Texas System · Granted Oct 1, 2019 · Expires Sep 26, 2039

    granted
  14. US 10428133

    Codon optimized IL-15 and IL-15R-alpha genes for expression in mammalian cells

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 1, 2019 · Expires Sep 26, 2039

    granted
  15. US 10426771

    6-hydroxy-2,5,7,8-tetramethylchroman-compounds for the treatment of chronic obstructive airway diseases

    Sulfateq B.V. · Granted Oct 1, 2019 · Expires Sep 26, 2039

    granted
  16. US 10428025

    Antifungal compound process

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 1, 2019 · Expires Sep 26, 2039

    granted
  17. US 10428313

    Chimeric West Nile/Dengue viruses and methods of use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 1, 2019 · Expires Sep 26, 2039

    granted
  18. US 10426736

    Delivering functional nucleic acids to mammalian cells via bacterially-derived, intact minicells

    EnGeneIC Molecular Delivery Pty Ltd · Granted Oct 1, 2019 · Expires Sep 26, 2039

    granted
  19. US 10426797

    Compositions and methods for treating cancer with anti-CD33 immunotherapy

    United State of America, As Represented by the Secretary, Dept. of Health and Human Services · Granted Oct 1, 2019 · Expires Sep 26, 2039

    granted
  20. US 10428159

    Blocking monoclonal antibodies to AGR2 and its receptor C4.4A

    The Board of Regents of the University of Texas System · Granted Oct 1, 2019 · Expires Sep 26, 2039

    granted
  21. US 10426146

    Non-human animals having a humanized signal-regulatory protein gene

    REGENERON PHARMACEUTICALS, INC. · Granted Oct 1, 2019 · Expires Sep 26, 2039

    granted
  22. US 10428023

    Heterocyclic compound and use thereof

    Takeda Pharmaceutical Company Limited · Granted Oct 1, 2019 · Expires Sep 26, 2039

    granted
  23. US 10428013

    Amide compound, preparation method and uses thereof

    China State Institute of Pharmaceutical Industry · Granted Oct 1, 2019 · Expires Sep 26, 2039

    granted
  24. US 10426807

    Bone and joint protection composition and use thereof

    INFINITUS (CHINA) COMPANY LTD. · Granted Oct 1, 2019 · Expires Sep 26, 2039

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.